Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Uber stock rises as BART app adds Uber booking, with earnings next up

Uber stock rises as BART app adds Uber booking, with earnings next up

New York, Jan 21, 2026, 12:48 EST — Regular session Shares of Uber Technologies ticked up Wednesday following an announcement from San Francisco Bay Area Rapid Transit that riders can now book and pay for Uber trips directly through the agency’s mobile app. The tie-up comes as investors weigh demand and margins ahead of Uber’s quarterly earnings, a key trigger…
21 January 2026
Corvus Pharmaceuticals stock (CRVS) swings as $150M share sale follows eczema-data surge

Corvus Pharmaceuticals stock (CRVS) swings as $150M share sale follows eczema-data surge

New York, Jan 21, 2026, 12:27 EST — Regular session Shares of Corvus Pharmaceuticals edged up 0.3% to $21.48 by 12:11 p.m. EST Wednesday, swinging between $19.05 and a peak of $23.96 during a volatile session sparked by the company’s fresh capital-raising announcement. The moves carry weight since Corvus remains a clinical-stage firm. Following a strong rally on initial eczema…
21 January 2026
Texas Instruments stock price rises as chip shares rebound; TXN earnings next week in focus

Texas Instruments stock price rises as chip shares rebound; TXN earnings next week in focus

New York, January 21, 2026, 12:20 PM EST — Regular session Texas Instruments (TXN) shares bounced back Wednesday, rising about 2.2% to reach $193.82 by midday in New York, following an earlier drop near $189. The bounce stands out because Texas Instruments usually acts as a gauge for industrial demand, and its stock nears earnings amid volatile markets. Traders have…
RAPT stock hovers near $58 as GSK buyout puts tender offer clock in focus

RAPT stock hovers near $58 as GSK buyout puts tender offer clock in focus

New York, Jan 21, 2026, 12:09 EST — Regular session. RAPT Therapeutics (RAPT.O) held steady on Wednesday, trading around $57.60 midday on Nasdaq. The shares ticked up just 0.05% during the session. After Tuesday’s sharp reprice, the shares are trading more like a deal spread than a high-flying biotech stock. That matters because what’s next largely boils down to routine…
Lumentum stock price jumps again after $500 target call ahead of Feb. 3 earnings

Lumentum stock price jumps again after $500 target call ahead of Feb. 3 earnings

New York, Jan 21, 2026, 11:43 (EST) — Regular session Lumentum Holdings Inc shares rose about 5% to $374.52 in late-morning trading Wednesday, extending a solid rally. Aletheia Capital raised its price target for the optical components maker from $330 to $500, according to Investing.com. (Investing) This change matters because investors often treat Lumentum as a fast gauge of spending…
Intuit stock price dips again as Morgan Stanley maps a “Triple Double” path for INTU

Intuit stock price dips again as Morgan Stanley maps a “Triple Double” path for INTU

New York, Jan 21, 2026, 11:39 ET — Regular session Shares of Intuit Inc dipped roughly 0.6% on Wednesday, slipping to $525.93 despite Morgan Stanley’s bullish long-term outlook, which sees the stock potentially doubling in value. This move is crucial as Intuit enters the core of U.S. tax season, a key window for its TurboTax arm and investor sentiment. Shares…
P&G stock slips as earnings near; what PG investors watch on Thursday

P&G stock slips as earnings near; what PG investors watch on Thursday

New York, Jan 21, 2026, 11:55 ET — Regular session Procter & Gamble shares fell 0.7% on Wednesday as investors positioned ahead of the consumer-products maker’s quarterly results due Thursday. The stock was down $1.06 at $145.94 in late-morning trade, after swinging between $145.43 and $147.38. The report matters because P&G is an early read on how much pricing power…
Qualcomm stock rebounds as QCOM sets Feb. 4 earnings date after long slide

Qualcomm stock rebounds as QCOM sets Feb. 4 earnings date after long slide

New York, January 21, 2026, 11:58 a.m. ET — Regular session QUALCOMM Incorporated (QCOM.O) shares climbed roughly 1.5% to $156.36 by late morning Wednesday, following the announcement of its upcoming quarterly earnings release date. The timing is crucial as the stock has been falling for several days, with investors hungry for fresh insights on demand and margins amid a tough…
3M stock price today: MMM steadies after earnings slide as tariff risk clouds 2026 outlook

3M stock price today: MMM steadies after earnings slide as tariff risk clouds 2026 outlook

New York, January 21, 2026, 11:56 EST — Regular session 3M shares climbed 0.7% to $157.26 in late morning trading Wednesday, recovering some ground after the sharp drop the day before as investors weighed the company’s 2026 forecast. 3M’s stock swing rippled through the Dow. Its $11.62 decline Tuesday was among the largest drags on the price-weighted index, which sank…
Chevron stock price rises after report flags $1 billion-plus Singapore asset sale talks

Chevron stock price rises after report flags $1 billion-plus Singapore asset sale talks

New York, January 21, 2026, 12:00 ET — Regular session Chevron shares climbed Wednesday after reports surfaced that the U.S. oil giant is nearing a deal to sell refining and fuel distribution assets in Singapore, a transaction worth $1 billion or more. The stock gained $2.37, or 1.4%, hitting $167.67 by midday. (Reuters) The possible sale is significant as it…
Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play

Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play

New York, January 21, 2026, 11:55 AM EST — Regular session Shares of Boston Scientific Corporation held steady, edging just above $91.20 during late morning trading in New York on Wednesday. The stock is steady, with investors weighing a device-safety warning from U.S. regulators while watching Boston Scientific’s latest deal moves. Attention remains on the company’s planned Penumbra acquisition, sparking…
Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus

Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus

New York, January 21, 2026, 11:46 EST — Regular session Thermo Fisher Scientific Inc (NYSE: TMO) shares climbed roughly 1.9% to $630.48 Wednesday, outpacing the broader market as investors digested new regulatory developments around its planned Clario acquisition. The stock hit an intraday high of $631.25 earlier in the session. The Australian Competition and Consumer Commission (ACCC) has launched a…
1 56 57 58 59 60 812

Stock Market Today

  • S&P 500 Semiconductor Equipment Stocks Surge with Booming Chip Industry in 2026
    January 25, 2026, 8:24 AM EST. S&P 500 Semiconductor Equipment & Materials stocks are up double digits in 2026, standing out amid a flat overall market. Applied Materials, Lam Research, KLA, Teradyne, and Qnity Electronics have surged between 19.8% and 33.4% since January. These companies supply the machinery for chip and display production, benefiting from soaring semiconductor sales driven by artificial intelligence (AI) and data center demand. Semiconductor industry valuations are expected to reach up to $1.8 trillion by 2030, according to McKinsey, surpassing previous estimates. Major chipmakers like Taiwan Semiconductor (TSMC) plan record capital expenditures, with TSMC's 2026 capex rising to $52-$56 billion, fueling demand for semiconductor fab equipment. This positions semiconductor equipment makers as key beneficiaries of the expanding chip market.
Go toTop